

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.45245537 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.45245537 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.31768266 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.60488263 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60488263 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.41117213 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 4.30008470 |
| 8 | detection of other organism (GO:0098543) | 3.89232694 |
| 9 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.86632596 |
| 10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.78495648 |
| 11 | detection of bacterium (GO:0016045) | 3.77414127 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69316832 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69316832 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.69316832 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69316832 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.69316832 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69316832 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.68341336 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63122298 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.62270169 |
| 21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50078446 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.46370476 |
| 23 | * macrophage activation involved in immune response (GO:0002281) | 3.44787155 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42044428 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.41529705 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.38963202 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 3.37799976 |
| 28 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32092085 |
| 29 | growth hormone receptor signaling pathway (GO:0060396) | 3.31266094 |
| 30 | response to type I interferon (GO:0034340) | 3.23475715 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.21893631 |
| 32 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.18663947 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.17259638 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.17259638 |
| 35 | positive regulation of p38MAPK cascade (GO:1900745) | 3.10474660 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09412550 |
| 37 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07471732 |
| 38 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.07469847 |
| 39 | regulation of integrin activation (GO:0033623) | 3.02668777 |
| 40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00957514 |
| 41 | apoptotic cell clearance (GO:0043277) | 3.00896342 |
| 42 | positive regulation of interferon-alpha production (GO:0032727) | 3.00156400 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 2.99644600 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 2.99588911 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98138757 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97904672 |
| 47 | positive thymic T cell selection (GO:0045059) | 2.97108870 |
| 48 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.97084867 |
| 49 | detection of biotic stimulus (GO:0009595) | 2.97023829 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.96624285 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 2.96505353 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 2.95641142 |
| 53 | cellular extravasation (GO:0045123) | 2.95352105 |
| 54 | response to peptidoglycan (GO:0032494) | 2.93899792 |
| 55 | regulation of interferon-alpha production (GO:0032647) | 2.87358874 |
| 56 | regulation of response to interferon-gamma (GO:0060330) | 2.86158170 |
| 57 | positive regulation of histone deacetylation (GO:0031065) | 2.85708477 |
| 58 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85644897 |
| 59 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.83161630 |
| 60 | T-helper 1 type immune response (GO:0042088) | 2.81236813 |
| 61 | hemidesmosome assembly (GO:0031581) | 2.81142249 |
| 62 | positive regulation of type 2 immune response (GO:0002830) | 2.79227006 |
| 63 | cellular response to growth hormone stimulus (GO:0071378) | 2.78822790 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77893376 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77282084 |
| 66 | regulation of antigen processing and presentation (GO:0002577) | 2.76772341 |
| 67 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.76614803 |
| 68 | myeloid dendritic cell differentiation (GO:0043011) | 2.76111682 |
| 69 | germinal center formation (GO:0002467) | 2.72528656 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70541095 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.69546876 |
| 72 | regulation of type 2 immune response (GO:0002828) | 2.69384140 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.68104996 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 2.67528599 |
| 75 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67291927 |
| 76 | protein localization to endosome (GO:0036010) | 2.66844151 |
| 77 | leukocyte aggregation (GO:0070486) | 2.66318819 |
| 78 | negative regulation of granulocyte differentiation (GO:0030853) | 2.65826353 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.64495017 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61759462 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 2.60776471 |
| 82 | negative regulation of type 2 immune response (GO:0002829) | 2.60725628 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 2.59167961 |
| 84 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.58356380 |
| 85 | cell adhesion mediated by integrin (GO:0033627) | 2.58149174 |
| 86 | low-density lipoprotein particle clearance (GO:0034383) | 2.56567206 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.56410303 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 2.56407638 |
| 89 | regulation of cholesterol storage (GO:0010885) | 2.55393416 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55227601 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54005340 |
| 92 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53383924 |
| 93 | respiratory burst (GO:0045730) | 2.52671175 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.51084736 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.50916191 |
| 96 | response to protozoan (GO:0001562) | 2.48430624 |
| 97 | regulation of B cell differentiation (GO:0045577) | 2.48270161 |
| 98 | tolerance induction (GO:0002507) | 2.47618441 |
| 99 | JAK-STAT cascade (GO:0007259) | 2.46961370 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45763395 |
| 101 | regulation of podosome assembly (GO:0071801) | 2.45007785 |
| 102 | thymic T cell selection (GO:0045061) | 2.44310877 |
| 103 | dendritic cell differentiation (GO:0097028) | 2.43720990 |
| 104 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43326632 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 2.42953702 |
| 106 | establishment of endothelial barrier (GO:0061028) | 2.42768590 |
| 107 | B cell mediated immunity (GO:0019724) | 2.41967830 |
| 108 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.41066635 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40779681 |
| 110 | * myeloid cell activation involved in immune response (GO:0002275) | 2.40456324 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39583264 |
| 112 | response to host immune response (GO:0052572) | 2.39583264 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.38882249 |
| 114 | defense response to protozoan (GO:0042832) | 2.38757482 |
| 115 | mannose metabolic process (GO:0006013) | 2.38084387 |
| 116 | response to host (GO:0075136) | 2.37889466 |
| 117 | response to host defenses (GO:0052200) | 2.37889466 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37889466 |
| 119 | response to interferon-alpha (GO:0035455) | 2.35705385 |
| 120 | positive regulation of interferon-beta production (GO:0032728) | 2.35608785 |
| 121 | endothelial tube morphogenesis (GO:0061154) | 2.35042450 |
| 122 | morphogenesis of an endothelium (GO:0003159) | 2.35042450 |
| 123 | regulation of necroptotic process (GO:0060544) | 2.34675229 |
| 124 | negative regulation of stress fiber assembly (GO:0051497) | 2.32611528 |
| 125 | endothelial cell chemotaxis (GO:0035767) | 2.32522886 |
| 126 | neutrophil activation (GO:0042119) | 2.31155749 |
| 127 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.29917933 |
| 128 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.29899606 |
| 129 | negative regulation of interleukin-8 production (GO:0032717) | 2.29868852 |
| 130 | pinocytosis (GO:0006907) | 2.29497126 |
| 131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.29406861 |
| 132 | response to interleukin-15 (GO:0070672) | 2.28795757 |
| 133 | natural killer cell differentiation (GO:0001779) | 2.28594794 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28324236 |
| 135 | cellular response to interferon-gamma (GO:0071346) | 2.28178310 |
| 136 | mature B cell differentiation (GO:0002335) | 2.26891030 |
| 137 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.26510901 |
| 138 | granulocyte activation (GO:0036230) | 2.25398901 |
| 139 | regulation of p38MAPK cascade (GO:1900744) | 2.24951497 |
| 140 | hepatocyte apoptotic process (GO:0097284) | 2.23356779 |
| 141 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.22413496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.18048268 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80612423 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.76927057 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.65380203 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.51109425 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22450905 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99040265 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84750589 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.68099096 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.50896258 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50646146 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42196331 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41456506 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40629595 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39927102 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35714802 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34962747 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32534017 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.18009991 |
| 20 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13392994 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11528988 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09528146 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.08433852 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08030724 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04391268 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99920321 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94390499 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84349963 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83917501 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80748155 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78042735 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77079073 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76059874 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73521157 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.72806091 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70667766 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70064253 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67882810 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67800560 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.65177204 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64297165 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60881888 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59089217 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58797264 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57765357 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56992235 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55628320 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52710069 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51935317 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48739241 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47524691 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.44627821 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43814691 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42215300 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39753597 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32527142 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31856354 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31405443 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30655466 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29311993 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29222261 |
| 62 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28473977 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26563025 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26135662 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.25431293 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24362931 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23070371 |
| 68 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22902476 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22763784 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21908681 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21443186 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21165733 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20554181 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20506418 |
| 75 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19333310 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19057239 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18217774 |
| 78 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18047992 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18047992 |
| 80 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17734969 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17062510 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16491087 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16478400 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15319989 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14512406 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14279262 |
| 87 | * P68_20966046_ChIP-Seq_HELA_Human | 1.13734442 |
| 88 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12709831 |
| 89 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10506641 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09795169 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09605561 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09406731 |
| 93 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07900498 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07211994 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06579397 |
| 96 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.06550854 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06395627 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06372108 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05855540 |
| 100 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05565382 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03744142 |
| 102 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01636282 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01570896 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01441227 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01171023 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01011860 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00409753 |
| 108 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00243544 |
| 109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00091404 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98902186 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98730249 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98487631 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98068349 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97707457 |
| 115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97664540 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96775967 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96597077 |
| 118 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96039093 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94203113 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93751584 |
| 121 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92679843 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92395200 |
| 123 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90658409 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88973653 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88598482 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88540228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.10351378 |
| 2 | MP0003300_gastrointestinal_ulcer | 2.85786537 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.79118047 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.66536760 |
| 5 | MP0009278_abnormal_bone_marrow | 2.63743532 |
| 6 | MP0003436_decreased_susceptibility_to | 2.63428209 |
| 7 | MP0000685_abnormal_immune_system | 2.56452913 |
| 8 | MP0004510_myositis | 2.53247548 |
| 9 | MP0005451_abnormal_body_composition | 2.39613088 |
| 10 | MP0005387_immune_system_phenotype | 2.38567057 |
| 11 | MP0001790_abnormal_immune_system | 2.38567057 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.38022739 |
| 13 | MP0002254_reproductive_system_inflammat | 2.31419434 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.17801163 |
| 15 | MP0003724_increased_susceptibility_to | 2.14516595 |
| 16 | MP0001800_abnormal_humoral_immune | 2.08698678 |
| 17 | MP0004947_skin_inflammation | 2.05545369 |
| 18 | MP0009785_altered_susceptibility_to | 2.00862007 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.98423160 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.97944263 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.95147008 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.94217753 |
| 23 | MP0002419_abnormal_innate_immunity | 1.93330798 |
| 24 | MP0005025_abnormal_response_to | 1.90217304 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.84922237 |
| 26 | MP0008260_abnormal_autophagy | 1.82028256 |
| 27 | MP0005023_abnormal_wound_healing | 1.77325089 |
| 28 | MP0002723_abnormal_immune_serum | 1.77175908 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.73147762 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.69938371 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.69938371 |
| 32 | MP0002405_respiratory_system_inflammati | 1.67192131 |
| 33 | MP0001819_abnormal_immune_cell | 1.65978037 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.65921011 |
| 35 | MP0001873_stomach_inflammation | 1.65552844 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.64968301 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.64416863 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.62091776 |
| 39 | MP0001853_heart_inflammation | 1.60749015 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.57953238 |
| 41 | MP0006082_CNS_inflammation | 1.56061369 |
| 42 | MP0002006_tumorigenesis | 1.54059483 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.53587321 |
| 44 | MP0003448_altered_tumor_morphology | 1.52995258 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.52292008 |
| 46 | MP0009840_abnormal_foam_cell | 1.50790420 |
| 47 | MP0005671_abnormal_response_to | 1.50193615 |
| 48 | MP0003091_abnormal_cell_migration | 1.46266264 |
| 49 | MP0002398_abnormal_bone_marrow | 1.44728150 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.42730248 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.41899744 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.41362825 |
| 53 | MP0010307_abnormal_tumor_latency | 1.40840623 |
| 54 | MP0005275_abnormal_skin_tensile | 1.37701073 |
| 55 | MP0000716_abnormal_immune_system | 1.35903441 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.34765186 |
| 57 | MP0004858_abnormal_nervous_system | 1.34584840 |
| 58 | MP0002933_joint_inflammation | 1.30217188 |
| 59 | MP0001851_eye_inflammation | 1.29552413 |
| 60 | MP0003045_fibrosis | 1.28066276 |
| 61 | MP0008004_abnormal_stomach_pH | 1.26527023 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.25404239 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.25028398 |
| 64 | MP0002722_abnormal_immune_system | 1.22801765 |
| 65 | MP0003279_aneurysm | 1.21064935 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.18431375 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.17810165 |
| 68 | MP0002429_abnormal_blood_cell | 1.17236007 |
| 69 | MP0000858_altered_metastatic_potential | 1.16791077 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.15977095 |
| 71 | MP0001958_emphysema | 1.14306158 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.13982701 |
| 73 | MP0000343_altered_response_to | 1.13504583 |
| 74 | MP0002060_abnormal_skin_morphology | 1.12853920 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.12019421 |
| 76 | MP0005166_decreased_susceptibility_to | 1.11476730 |
| 77 | MP0004381_abnormal_hair_follicle | 1.10858744 |
| 78 | MP0000733_abnormal_muscle_development | 1.10305294 |
| 79 | MP0005164_abnormal_response_to | 1.08382084 |
| 80 | MP0005310_abnormal_salivary_gland | 1.06409413 |
| 81 | MP0008469_abnormal_protein_level | 1.03968693 |
| 82 | MP0003828_pulmonary_edema | 1.02337474 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.02141022 |
| 84 | MP0003866_abnormal_defecation | 1.00387140 |
| 85 | MP0000767_abnormal_smooth_muscle | 1.00249100 |
| 86 | MP0001849_ear_inflammation | 0.99688364 |
| 87 | MP0005390_skeleton_phenotype | 0.96772100 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.94207313 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.93834100 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.93246795 |
| 91 | MP0006054_spinal_hemorrhage | 0.93082904 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.90859073 |
| 93 | MP0004883_abnormal_blood_vessel | 0.90585093 |
| 94 | MP0001243_abnormal_dermal_layer | 0.88534052 |
| 95 | MP0003075_altered_response_to | 0.86805679 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.86693102 |
| 97 | MP0003690_abnormal_glial_cell | 0.85863040 |
| 98 | MP0000490_abnormal_crypts_of | 0.85860533 |
| 99 | MP0009764_decreased_sensitivity_to | 0.85178199 |
| 100 | MP0002796_impaired_skin_barrier | 0.84979479 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.84472307 |
| 102 | MP0005409_darkened_coat_color | 0.83581860 |
| 103 | MP0001663_abnormal_digestive_system | 0.83291140 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.80670453 |
| 105 | MP0000249_abnormal_blood_vessel | 0.80253288 |
| 106 | MP0005666_abnormal_adipose_tissue | 0.77430974 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.76998660 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.75844713 |
| 109 | MP0000609_abnormal_liver_physiology | 0.75640688 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.73257235 |
| 111 | MP0001915_intracranial_hemorrhage | 0.72913593 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.72582916 |
| 113 | MP0009931_abnormal_skin_appearance | 0.71526818 |
| 114 | MP0002132_abnormal_respiratory_system | 0.70739676 |
| 115 | MP0000604_amyloidosis | 0.70632077 |
| 116 | MP0009763_increased_sensitivity_to | 0.70572381 |
| 117 | MP0003795_abnormal_bone_structure | 0.70185921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.50789612 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.30325306 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29922303 |
| 4 | Myositis (HP:0100614) | 3.24838584 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.18878432 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15843072 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15843072 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15843072 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.15350204 |
| 10 | Myocardial infarction (HP:0001658) | 3.12931990 |
| 11 | Peritonitis (HP:0002586) | 3.05315003 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 3.03730826 |
| 13 | Increased IgE level (HP:0003212) | 3.03694570 |
| 14 | Stomatitis (HP:0010280) | 3.03550082 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.01505562 |
| 16 | Cellulitis (HP:0100658) | 2.94772138 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 2.94603738 |
| 18 | Chronic otitis media (HP:0000389) | 2.92009387 |
| 19 | Orchitis (HP:0100796) | 2.90030677 |
| 20 | Nasal polyposis (HP:0100582) | 2.89874578 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 2.87752664 |
| 22 | Loss of speech (HP:0002371) | 2.81495295 |
| 23 | Hematochezia (HP:0002573) | 2.81176924 |
| 24 | Osteolytic defects of the hand bones (HP:0009699) | 2.80343329 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.80343329 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 2.75915292 |
| 27 | Recurrent viral infections (HP:0004429) | 2.71473646 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65062242 |
| 29 | Obstructive lung disease (HP:0006536) | 2.65062242 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.61954586 |
| 31 | Colitis (HP:0002583) | 2.60540409 |
| 32 | Pustule (HP:0200039) | 2.58500066 |
| 33 | Thin bony cortex (HP:0002753) | 2.58297908 |
| 34 | Premature rupture of membranes (HP:0001788) | 2.55053912 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.54410577 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.53740072 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.52586129 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44152888 |
| 39 | Gingivitis (HP:0000230) | 2.42254349 |
| 40 | Aortic aneurysm (HP:0004942) | 2.41696427 |
| 41 | Increased connective tissue (HP:0009025) | 2.40009958 |
| 42 | Malnutrition (HP:0004395) | 2.39567722 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.37767755 |
| 44 | Periodontitis (HP:0000704) | 2.37288920 |
| 45 | Increased density of long bones (HP:0006392) | 2.37217389 |
| 46 | Emphysema (HP:0002097) | 2.37099024 |
| 47 | Persistence of primary teeth (HP:0006335) | 2.36647898 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.36626848 |
| 49 | Recurrent bronchitis (HP:0002837) | 2.36359606 |
| 50 | Thick nail (HP:0001805) | 2.33667163 |
| 51 | Broad face (HP:0000283) | 2.32739398 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.32623934 |
| 53 | Atrophic scars (HP:0001075) | 2.31896277 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.30962734 |
| 55 | Amyloidosis (HP:0011034) | 2.29300667 |
| 56 | Thrombocytosis (HP:0001894) | 2.29162252 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28693667 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28693667 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28693667 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.28162362 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27366182 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27366182 |
| 63 | Arterial thrombosis (HP:0004420) | 2.26314627 |
| 64 | Recurrent skin infections (HP:0001581) | 2.26115059 |
| 65 | Cervical subluxation (HP:0003308) | 2.22399463 |
| 66 | Urticaria (HP:0001025) | 2.22095185 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.22011569 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22011569 |
| 69 | Milia (HP:0001056) | 2.21885495 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21372196 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.18634581 |
| 72 | Vasculitis (HP:0002633) | 2.17818029 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.15786100 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15175466 |
| 75 | Encephalitis (HP:0002383) | 2.14164117 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.13256567 |
| 77 | Dilatation of the ascending aorta (HP:0005111) | 2.12084474 |
| 78 | Increased serum ferritin (HP:0003281) | 2.11735083 |
| 79 | Shallow orbits (HP:0000586) | 2.10944820 |
| 80 | Mitral valve prolapse (HP:0001634) | 2.07428181 |
| 81 | Esophageal varix (HP:0002040) | 2.06201329 |
| 82 | Ankle contracture (HP:0006466) | 2.06188062 |
| 83 | Gingival bleeding (HP:0000225) | 2.03478708 |
| 84 | Aortic dissection (HP:0002647) | 2.02916263 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.01752875 |
| 86 | Ulnar bowing (HP:0003031) | 2.00923697 |
| 87 | Abnormal platelet volume (HP:0011876) | 2.00445988 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 2.00095083 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 1.99104196 |
| 90 | Optic neuritis (HP:0100653) | 1.99104196 |
| 91 | Premature loss of primary teeth (HP:0006323) | 1.98797070 |
| 92 | Leukocytosis (HP:0001974) | 1.97916804 |
| 93 | Aneurysm (HP:0002617) | 1.97013363 |
| 94 | Polycythemia (HP:0001901) | 1.95895860 |
| 95 | Pulmonary infiltrates (HP:0002113) | 1.95776092 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.93711791 |
| 97 | Skin ulcer (HP:0200042) | 1.93393637 |
| 98 | Distal upper limb amyotrophy (HP:0007149) | 1.92875397 |
| 99 | Upper limb amyotrophy (HP:0009129) | 1.92875397 |
| 100 | Osteomyelitis (HP:0002754) | 1.91411554 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 1.91307718 |
| 102 | Epistaxis (HP:0000421) | 1.91282463 |
| 103 | Abnormal platelet function (HP:0011869) | 1.91111871 |
| 104 | Impaired platelet aggregation (HP:0003540) | 1.91111871 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90480570 |
| 106 | Increased IgM level (HP:0003496) | 1.89884220 |
| 107 | Purpura (HP:0000979) | 1.88223285 |
| 108 | Nuclear cataract (HP:0100018) | 1.87999142 |
| 109 | Slow saccadic eye movements (HP:0000514) | 1.87300405 |
| 110 | Prolonged bleeding time (HP:0003010) | 1.87208965 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.87021555 |
| 112 | Fatigue (HP:0012378) | 1.86395055 |
| 113 | Polygenic inheritance (HP:0010982) | 1.86106866 |
| 114 | IgM deficiency (HP:0002850) | 1.85463169 |
| 115 | Gangrene (HP:0100758) | 1.83886003 |
| 116 | Abnormality of the peritoneum (HP:0002585) | 1.82415926 |
| 117 | Chest pain (HP:0100749) | 1.82010710 |
| 118 | Eosinophilia (HP:0001880) | 1.82000760 |
| 119 | Episodic fever (HP:0001954) | 1.81726310 |
| 120 | Pulmonary embolism (HP:0002204) | 1.79729522 |
| 121 | Hemoptysis (HP:0002105) | 1.79666748 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 1.79227567 |
| 123 | Broad metatarsal (HP:0001783) | 1.78116235 |
| 124 | T lymphocytopenia (HP:0005403) | 1.78110574 |
| 125 | Anorexia (HP:0002039) | 1.77822076 |
| 126 | Spondylolisthesis (HP:0003302) | 1.77401191 |
| 127 | Alopecia of scalp (HP:0002293) | 1.77396473 |
| 128 | Radial bowing (HP:0002986) | 1.76964492 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.76643977 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.76499602 |
| 131 | Syringomyelia (HP:0003396) | 1.75898168 |
| 132 | Spinal cord lesions (HP:0100561) | 1.75898168 |
| 133 | Neurofibrillary tangles (HP:0002185) | 1.75540524 |
| 134 | Acne (HP:0001061) | 1.75211087 |
| 135 | Tetraparesis (HP:0002273) | 1.72841127 |
| 136 | Meningitis (HP:0001287) | 1.70010995 |
| 137 | IgA deficiency (HP:0002720) | 1.69457353 |
| 138 | Gastrointestinal infarctions (HP:0005244) | 1.68130246 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.66212758 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 1.66087689 |
| 141 | Axonal loss (HP:0003447) | 1.65079436 |
| 142 | Hand muscle atrophy (HP:0009130) | 1.64761717 |
| 143 | Panhypogammaglobulinemia (HP:0003139) | 1.64589987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.66125531 |
| 2 | MAP4K1 | 3.09303654 |
| 3 | EPHB1 | 3.02223911 |
| 4 | TRIB3 | 3.01181706 |
| 5 | PRPF4B | 2.94124803 |
| 6 | FGFR4 | 2.78497713 |
| 7 | TYK2 | 2.74770053 |
| 8 | EPHA3 | 2.55345575 |
| 9 | JAK3 | 2.36329137 |
| 10 | MAP3K14 | 2.26877068 |
| 11 | TBK1 | 2.21274536 |
| 12 | EEF2K | 2.15630825 |
| 13 | PKN2 | 2.08801908 |
| 14 | MAP3K10 | 2.03386115 |
| 15 | RIPK1 | 1.95022304 |
| 16 | JAK1 | 1.94961201 |
| 17 | TTN | 1.92871408 |
| 18 | CDK12 | 1.92523999 |
| 19 | SMG1 | 1.89827884 |
| 20 | TGFBR2 | 1.78936268 |
| 21 | STK10 | 1.77080432 |
| 22 | KIT | 1.72864783 |
| 23 | TAOK2 | 1.71361147 |
| 24 | PTK6 | 1.67945593 |
| 25 | IKBKE | 1.58780849 |
| 26 | IKBKB | 1.55662814 |
| 27 | CDC42BPA | 1.54775630 |
| 28 | FGFR3 | 1.50217797 |
| 29 | ZAP70 | 1.47047325 |
| 30 | MAP2K3 | 1.42936425 |
| 31 | LRRK2 | 1.39217444 |
| 32 | RPS6KA4 | 1.38587751 |
| 33 | TNK2 | 1.37933552 |
| 34 | ICK | 1.36384612 |
| 35 | BLK | 1.34894998 |
| 36 | SIK1 | 1.34679221 |
| 37 | MAP3K3 | 1.34525452 |
| 38 | CHUK | 1.32916725 |
| 39 | GRK6 | 1.31029749 |
| 40 | CSK | 1.27141284 |
| 41 | NME2 | 1.22941938 |
| 42 | SIK3 | 1.22448267 |
| 43 | IRAK3 | 1.21250716 |
| 44 | FGR | 1.19203920 |
| 45 | BMX | 1.16638992 |
| 46 | MARK2 | 1.15859396 |
| 47 | CSF1R | 1.15314605 |
| 48 | HCK | 1.13778256 |
| 49 | MAP3K6 | 1.11839649 |
| 50 | PRKD2 | 1.11436231 |
| 51 | EPHA2 | 1.10371387 |
| 52 | MAP3K13 | 1.10157283 |
| 53 | NLK | 1.09759309 |
| 54 | BTK | 1.07506406 |
| 55 | JAK2 | 1.05052504 |
| 56 | DDR2 | 1.04302540 |
| 57 | PAK4 | 1.04095345 |
| 58 | KDR | 1.01483966 |
| 59 | PIM1 | 1.00276443 |
| 60 | PIM2 | 1.00101587 |
| 61 | CAMK1D | 0.99579755 |
| 62 | IRAK2 | 0.99563312 |
| 63 | IRAK4 | 0.97141145 |
| 64 | TAOK3 | 0.91965891 |
| 65 | TGFBR1 | 0.91522778 |
| 66 | FLT3 | 0.91045406 |
| 67 | ITK | 0.83419656 |
| 68 | SIK2 | 0.83177893 |
| 69 | TRPM7 | 0.82719922 |
| 70 | ALK | 0.81687259 |
| 71 | LCK | 0.81190443 |
| 72 | KSR2 | 0.80511459 |
| 73 | PDPK1 | 0.76008072 |
| 74 | GRK7 | 0.73611219 |
| 75 | MTOR | 0.73357014 |
| 76 | SYK | 0.71444520 |
| 77 | TXK | 0.70500096 |
| 78 | RPS6KC1 | 0.70457397 |
| 79 | RPS6KL1 | 0.70457397 |
| 80 | CDK6 | 0.70212684 |
| 81 | PTK2 | 0.69732931 |
| 82 | PDGFRA | 0.66854554 |
| 83 | TAOK1 | 0.65068144 |
| 84 | MAP3K11 | 0.64522325 |
| 85 | RPS6KA2 | 0.64493133 |
| 86 | MAPK7 | 0.63044986 |
| 87 | MATK | 0.62739864 |
| 88 | RPS6KB2 | 0.61503895 |
| 89 | MARK3 | 0.60817431 |
| 90 | MOS | 0.60660911 |
| 91 | MAP3K7 | 0.60660319 |
| 92 | PDK1 | 0.59994605 |
| 93 | PAK2 | 0.59960736 |
| 94 | TEC | 0.59311069 |
| 95 | MAPKAPK3 | 0.56966062 |
| 96 | MAPKAPK2 | 0.55343211 |
| 97 | MAP3K8 | 0.54124749 |
| 98 | PDGFRB | 0.53012685 |
| 99 | HIPK2 | 0.52003204 |
| 100 | CAMK1G | 0.51431427 |
| 101 | RIPK4 | 0.50656616 |
| 102 | NEK9 | 0.50298269 |
| 103 | MAP2K6 | 0.49985778 |
| 104 | EGFR | 0.49444676 |
| 105 | TESK2 | 0.48863466 |
| 106 | DMPK | 0.47228795 |
| 107 | STK3 | 0.46411585 |
| 108 | IRAK1 | 0.45826469 |
| 109 | MAP3K1 | 0.45700673 |
| 110 | STK38 | 0.44798251 |
| 111 | TESK1 | 0.44459207 |
| 112 | MAPK12 | 0.44199276 |
| 113 | CDK4 | 0.43145132 |
| 114 | GSK3A | 0.42279917 |
| 115 | RPS6KA6 | 0.41762736 |
| 116 | CLK1 | 0.41010209 |
| 117 | PRKG2 | 0.40581644 |
| 118 | TIE1 | 0.40468524 |
| 119 | FES | 0.40229520 |
| 120 | SCYL2 | 0.39746049 |
| 121 | ABL1 | 0.39403681 |
| 122 | RET | 0.38491812 |
| 123 | NEK2 | 0.37420733 |
| 124 | LYN | 0.36786699 |
| 125 | TYRO3 | 0.36697009 |
| 126 | FYN | 0.36613113 |
| 127 | MAPK11 | 0.36585370 |
| 128 | PRKAA2 | 0.35714460 |
| 129 | MST1R | 0.33164030 |
| 130 | RPS6KA1 | 0.32827839 |
| 131 | INSR | 0.31664546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63757169 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40659967 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38832081 |
| 4 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.06549468 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99740872 |
| 6 | Malaria_Homo sapiens_hsa05144 | 1.98229063 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96607901 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91254806 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.88431805 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80731541 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76825046 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72341231 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68404813 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66261321 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61555483 |
| 16 | Apoptosis_Homo sapiens_hsa04210 | 1.61416040 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60837565 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60624578 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59708606 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.58567510 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56557408 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.55476616 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.55129487 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52887178 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.52615468 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48477234 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47388985 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45979712 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.43543300 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.41041741 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40299366 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40255100 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37394643 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32263266 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.29975919 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28669916 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25088107 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.23369553 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23310984 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.19994756 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18447194 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14415662 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.11079624 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10017404 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09886591 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09773098 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07807607 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.07730469 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07427751 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05295521 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04385140 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03936036 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.03625981 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.01786894 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98984228 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95336151 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95228854 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93349636 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93290200 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93252125 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92478543 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.92422814 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.92384703 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92053909 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.90090831 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89856897 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88787830 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88523818 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.86789450 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86390491 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86068111 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83508505 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82815847 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79970074 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77422666 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76899768 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76558054 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76025804 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74046364 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.72446552 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70150232 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69428110 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64455614 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.63634212 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61616051 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.61322699 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60973247 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58465726 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58321905 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58286531 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58073218 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57964448 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55927939 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55709401 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54767957 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53266180 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.52923736 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.51840440 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49546423 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49487629 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49417103 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.48831865 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.48650935 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48349260 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48190674 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46318491 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46206569 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45131111 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44196846 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43995566 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42790265 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41921927 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41832807 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40013154 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.39645893 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38110788 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34616085 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32514650 |

